Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014 - 2025

  • ID: 4076558
  • Report
  • Region: Global
  • 95 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • AbbVie, Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Boehringer Ingelheim GmbH
  • Cipla, Inc.
  • Merck& Co., Inc.
  • MORE

The global active pharmaceutical ingredients (API) market is expected to reach a value of USD 239.8 billion by 2025. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth.

Favorable government initiatives for increasing focus toward generic drugs is a key factor for market growth. Decrease in generic drug prices, higher acceptance in low income and decrease in reimbursement for branded drugs are the recent trends in the market affirming growth of generic drugs.

Further Key Findings from the Study Suggest:

Synthetic APIs was the largest segment by revenue share in 2015 owing to high demand.

Biotech APIs are estimated to grow lucratively over the forecast period with high R&D initiatives being undertaken for their development

Captive manufacturers, being the conventional option of API manufacturing, held the majority of the share.

On the other hand, the merchant manufacturers segment is expected to be fastest-growing due to growing outsourcing activities

Generic APIs will experience lucrative growth over the forecast period attributed to patent expirations of branded drugs

APIs are identified to have highest application in cardiovascular therapeutics. Increasing mortality caused by heart diseases and growing demand for fast-acting drugs are the major factors contributing to dominance

North America dominated in terms of revenue share in 2015 and Asia Pacific is expected to grow at a significant growth rate over the forecast period

Some of the major companies in the API market are AbbVie, Inc., Boehringer Ingelheim GmbH, Cipla, Inc., and Merck & Co., Inc.


PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie, Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Boehringer Ingelheim GmbH
  • Cipla, Inc.
  • Merck& Co., Inc.
  • MORE
1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources

2 Executive Summary
2.1 Market Snapshot

3 API Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
3.1.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.1.1.4 Increasing preference for outsourcing APIs
3.1.2 Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.1.3 Stringent safety and handling regulations regarding APIs
3.2 Penetration & growth prospect mapping
3.3 Active Pharmaceutical Ingredient - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s

4 API Market: Type of Synthesis Estimates & Trend Analysis
4.1 Active pharmaceutical ingredient market: Type of synthesis movement analysis
4.2 Biotech
4.2.1 Biotech market, 2014 - 2025 (USD Billion)
4.2.2 Monoclonal Antibodies
4.2.3 Monoclonal Antibodies market, 2014 - 2025 (USD Billion)
4.2.4 Recombinant proteins
4.2.5 Recombinant proteins market, 2014 - 2025 (USD Billion)
4.2.6 Vaccines
4.2.7 Vaccines market, 2014 - 2025 (USD Billion)
4.3 Synthetic
4.3.1 Synthetic market, 2014 - 2025 (USD Billion)

5 API Market: Type of Manufacturer Estimates & Trend Analysis
5.1 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
5.2 Captive APIs
5.2.1 Captive APIs market, 2014 - 2025 (USD Billion)
5.3 Merchant APIs
5.3.1 Merchant APIs market, 2014 - 2025 (USD Billion)

6 API Market: Type Estimates & Trend Analysis
6.1 Active pharmaceutical ingredient market: Type movement analysis
6.2 Generic APIs
6.2.1 Generic APIs market, 2014 - 2025 (USD Billion)
6.3 Innovative APIs
6.3.1 Innovative APIs market, 2014 - 2025 (USD Billion)

7 API Market: Application Estimates & Trend Analysis
7.1 Active pharmaceutical ingredient market: Application movement analysis
7.2 Cardiovascular Disease
7.2.1 Cardiovascular Disease market, 2014 - 2025 (USD Billion)
7.3 Oncology
7.3.1 Oncology market, 2014 - 2025 (USD Billion)
7.4 CNS and Neurological Disorders
7.4.1 CNS and Neurological Disorders market, 2014 - 2025 (USD Billion)
7.5 Orthopedic Disorders
7.5.1 Orthopedic Disorders market, 2014 - 2025 (USD Billion)
7.6 Endocrinology
7.6.1 Endocrinology market, 2014 - 2025 (USD Billion)
7.7 Pulmonology
7.7.1 Pulmonology market, 2014 - 2025 (USD Billion)
7.8 Gastrointestinal Disorders
7.8.1 Gastrointestinal Disorders market, 2014 - 2025 (USD Billion)
7.9 Nephrology
7.9.1 Nephrology market, 2014 - 2025 (USD Billion)
7.10 Ophthalmology
7.10.1 Ophthalmology market, 2014 - 2025 (USD Billion)
7.10.2 Others market, 2014 - 2025 (USD Billion)

8 API Market: Regional Estimates & Trend Analysis
8.1 Active pharmaceutical ingredient market share, by region, 2015 & 2025
8.2 North America
8.2.1 North America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.2.2 U.S
8.2.2.1 U.S active pharmaceutical Ingredient market, 2014 - 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.3 Europe
8.3.1 Europe active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.3.2 UK
8.3.2.1 UK active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.3.3 Germany
8.3.3.1 Germany active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.4.3 China
8.4.3.1 China active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.4.4 India
8.4.4.1 India active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.5.3 Mexico
8.5.3.1 Mexico active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.6 MEA
8.6.1 MEA active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)

9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 AbbVie, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Boehringer Ingelheim GmbH
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Bristol-Myers Squibb Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Cipla, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Merck& Co., Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Albemarle Corporation
9.3.6.1 Company overview
9.3.6.2 Financial overview
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Aurobindo Pharma
9.3.7.1 Company overview
9.3.7.2 Financial overview
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Mylan N.V.
9.3.8.1 Company overview
9.3.8.2 Financial overview
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Teva Active Pharmaceuticals Industries Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial overview
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Sun Pharmaceutical Industries, Ltd.
9.3.10.1 Company overview
9.3.10.2 Financial overview
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Dr. Reddy’s Laboratories Ltd
9.3.11.1 Company overview
9.3.11.2 Financial overview
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives

List of Tables

Table 1 Country share estimation
Table 2 North America active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 3 North America biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 4 North America active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 5 North America active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 6 North America active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 7 U.S. active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 8 U.S. biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 9 U.S. active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 10 U.S. active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 11 U.S. active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 12 Canada active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 13 Canada biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 14 Canada active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 15 Canada active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 16 Canada active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 17 Europe active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 18 Europe biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 19 Europe active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 20 Europe active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 21 Europe active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 22 UK active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 23 UK biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 24 UK active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 25 UK active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 26 UK active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 27 Germany active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 28 Germany biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 29 Germany active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 30 Germany active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 31 Germany active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 32 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 33 Asia Pacific biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 34 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 35 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 36 Asia Pacific active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 37 Japan active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 38 Japan biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 39 Japan active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 40 Japan active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 41 Japan active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 42 China active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 43 China biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 44 China active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 45 China active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 46 China active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 47 India active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 48 India biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 49 India active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 50 India active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 51 India active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 52 Latin America active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 53 Latin America biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 54 Latin America active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 55 Latin America active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 56 Latin America active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 57 Brazil active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 58 Brazil biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 59 Brazil active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 60 Brazil active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 61 Brazil active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 62 Mexico active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 63 Mexico biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 64 Mexico active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 65 Mexico active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 66 Mexico active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 67 MEA active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 68 MEA biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 69 MEA active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 70 MEA active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 71 MEA active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 72 South Africa active pharmaceutical ingredient market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Billion)
Table 73 South Africa biotech active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 74 South Africa active pharmaceutical ingredient market estimates and forecasts, by type of manufacturer, 2014 - 2025 (USD Billion)
Table 75 South Africa active pharmaceutical ingredient market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
Table 76 South Africa active pharmaceutical ingredient market estimates and forecasts, by application, 2014 - 2025 (USD Billion)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Value chain based sizing & forecasting
Figure 4 QFD modeling for market share assessment
Figure 5 Market summary
Figure 6 Market trends &outlook
Figure 7 Market segmentation & scope
Figure 8 Market driver relevance analysis (Current & future impact)
Figure 9 Global percentage of population, by age group, 2050 and 2000
Figure 10 Market restraint relevance analysis (Current & future impact)
Figure 11 Penetration & growth prospect mapping
Figure 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Active pharmaceutical ingredient market type of synthesis outlook key takeaways
Figure 15 Active pharmaceutical ingredient market: Type movement analysis
Figure 16 Global biotech market, 2014 - 2025 (USD Billion)
Figure 17 Global monoclonal Antibodies market, 2014 - 2025 (USD Billion)
Figure 18 Global recombinant proteins market, 2014 - 2025 (USD Billion)
Figure 19 Global vaccines market, 2014 - 2025 (USD Billion)
Figure 20 Global synthetic market, 2014 - 2025 (USD Billion)
Figure 21 Active pharmaceutical ingredient market type of manufacturer outlook key takeaways
Figure 22 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
Figure 23 Global Captive APIs market, 2014 - 2025 (USD Billion)
Figure 24 Global merchant APIs market, 2014 - 2025 (USD Billion)
Figure 25 Active pharmaceutical ingredient market type outlook key takeaways
Figure 26 Active pharmaceutical ingredient market: Type movement analysis
Figure 27 Global generic APIs market, 2014 - 2025 (USD Billion)
Figure 28 Global innovative APIs market, 2014 - 2025 (USD Billion)
Figure 29 Active pharmaceutical ingredient market application outlook key takeaways
Figure 30 Active pharmaceutical ingredient market: Application movement analysis
Figure 31 Global cardiovascular Disease market, 2014 - 2025 (USD Billion)
Figure 32 Global oncology market, 2014 - 2025 (USD Billion)
Figure 33 Global CNS and neurological disorders market, 2014 - 2025 (USD Billion)
Figure 34 Global orthopedic disorders market, 2014 - 2025 (USD Billion)
Figure 35 Global endocrinology market, 2014 - 2025 (USD Billion)
Figure 36 Global pulmonology market, 2014 - 2025 (USD Billion)
Figure 37 Global gastrointestinal disorders market, 2014 - 2025 (USD Billion)
Figure 38 Global nephrology market, 2014 - 2025 (USD Billion)
Figure 39 Global ophthalmology market, 2014 - 2025 (USD Billion)
Figure 40 Global ophthalmology market, 2014 - 2025 (USD Billion)
Figure 41 Regional market place: Key takeaways
Figure 42 Regional outlook, 2015 & 2025
Figure 43 North America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 44 U.S. active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 45 Canada active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 46 Europe active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 47 UK active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 48 Germany active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 49 Asia Pacific active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 50 Japan active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 51 China active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 52 India active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 53 Latin America active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 54 Brazil active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 55 Mexico active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 56 MEA active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 57 South Africa active pharmaceutical ingredient market, 2014 - 2025 (USD Billion)
Figure 58 Strategy framework
Figure 59 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cipla, Inc.
  • Merck& Co., Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Mylan N.V.
  • Teva Active Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries, Ltd.
  • Dr. Reddy’s Laboratories Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll